Organization
Xeris Pharmaceuticals
3 clinical trials
Clinical trial
A Phase 2, Multicenter, Non-Randomized, Open-Label, Single Arm, Self-controlled Study of XP-8121 For the Treatment of Adult Subjects With HypothyroidismStatus: Active (not recruiting), Estimated PCD: 2024-05-31
Clinical trial
A Phase 2, Single-Dose, Randomized, Open-Label, Active-Controlled, Crossover, Pharmacodynamic, and Pharmacokinetic Comparative Study of a Novel Pramlintide-Insulin Co-Formulation in Adults With Type 1 Diabetes MellitusStatus: Completed, Estimated PCD: 2020-04-02